Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02110108 · ClinicalTrials.gov registry record · NA
Study for the RevLite Laser System for Facial Solar Lentigines
A NA study of Facial Solar Lentigines, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT02110108: Completed NA study of Facial Solar Lentigines, sponsored by Cynosure.
NCT02110108 is a NA study of Facial Solar Lentigines that has completed, run by Cynosure. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02110108, a NA study of Facial Solar Lentigines, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effects of the Revlite Laser System for treatment of facial solar lentigines
Primary Outcome
Photos taken at baseline will be compared to photos taken 1 month post last treatment to assess the level of improvement using the Global Aesthetic Improvement Scale. This evaluation is blinded. This scale ranges from -1 to 3, where -1 is worsened, 0 is no change, 1 is improved, 2 is much improved, and 3 is very much improved.
Conditions Studied
Interventions
- DEVICE Revlite Laser System
Study Locations (1)
New York
- Sadick Research Group - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-02 |
| Phase | NA |
What the finished NCT02110108 record still lists
NCT02110108 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Facial Solar Lentigines appearing as the primary indexed condition, and to 1 intervention - of which Revlite Laser System is the first listed.
NCT02110108 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02110108 about?
NCT02110108 is a clinical study titled "Study for the RevLite Laser System for Facial Solar Lentigines". The purpose of this study is to evaluate the effects of the Revlite Laser System for treatment of facial solar lentigines
What is the current status of trial NCT02110108?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-03. Estimated completion is 2015-02.
What conditions does trial NCT02110108 study?
This clinical trial studies the following conditions: Facial Solar Lentigines.
What interventions are being tested in trial NCT02110108?
The interventions under investigation include: Revlite Laser System (DEVICE).
Who is sponsoring clinical trial NCT02110108?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02110108 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02110108's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia